Revealing one of the mechanisms by which thyroid cancer becomes resistant to lenvatinib-a
by Shinshu UniversityThe EGFR-mediated pathway, which is not targeted by lenvatinib, is activated for survival in thyroid cancer cells under the potent inhibition of the VEGFR and FGFR families by len
Updated on: December 26,2023
Revealing one of the mechanisms by which thyroid cancer becomes resistant to lenvatinib-a
by Shinshu UniversityThe EGFR-mediated pathway, which is not targeted by lenvatinib, is activated for survival in thyroid cancer cells under the potent inhibition of the VEGFR and FGFR families by len
Updated on:December 26,2023
